Skip to content
Search

Latest Stories

FreeStyle Libre 2 Sensors added to Drug Tariff and DND list  

The new FreeStyle Libre 2 Sensors recently launched by Abbott Diabetes Care Ltd have been added to the Appliances section in Part IXA of the November 2020 Drug Tariff.

The product is also included in the list of drugs for which discount is not deducted (DND).


The introduction of the second-generation FreeStyle Libre 2 Flash Glucose Monitoring system follows the launch of the original FreeStyle Libre system which saw a growth in prescribing after extra NHS funding was made available from April 2019.

“As there is no discount offered by the manufacturer for purchases of the FreeStyle Libre 2 Sensors, following representations by PSNC to avoid contractors dispensing this appliance at a loss, the Department of Health and Social Care (DHSC) agreed to its addition to the DND list,” Pharmaceutical Services Negotiating Committee (PSNC) has said.

FreeStyle Libre 2 Sensors are not interchangeable with FreeStyle Libre Sensors and require a different reader or the FreeStyle LibreLink app to scan and receive the results.

The arrangements for ordering the FreeStyle Libre 2 sensors remain the same as for the original sensors – via the Abbott Diabetes Care pharmacy ordering portal.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less